Bristol-Myers Squibb Given “Hold” Rating at Jefferies Group (BMY)
Bristol-Myers Squibb (NYSE:BMY)‘s stock had its “hold” rating restated by analysts at Jefferies Group in a research report issued to clients and investors on Friday, American Banking News.com reports.
Several other analysts have also recently commented on the stock. Analysts at Zacks upgraded shares of Bristol-Myers Squibb from an “underperform” rating to a “neutral” rating in a research note to investors on Wednesday. They now have a $49.00 price target on the stock. Separately, analysts at Credit Suisse initiated coverage on shares of Bristol-Myers Squibb in a research note to investors on Tuesday. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $47.80.
Shares of Bristol-Myers Squibb (NYSE:BMY) traded down 0.31% on Friday, hitting $47.69. The stock had a trading volume of 2,119,206 shares. Bristol-Myers Squibb has a one year low of $30.64 and a one year high of $49.57. The stock’s 50-day moving average is $44.65 and its 200-day moving average is $43.76. The company has a market cap of $78.513 billion and a P/E ratio of 58.41.
Bristol-Myers Squibb (NYSE:BMY) last released its earnings data on Thursday, July 25th. The company reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by $0.01. The company had revenue of $4.05 billion for the quarter, compared to the consensus estimate of $4.07 billion. During the same quarter in the previous year, the company posted $0.48 earnings per share. The company’s revenue for the quarter was down 8.9% on a year-over-year basis. Analysts expect that Bristol-Myers Squibb will post $1.74 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, November 1st. Investors of record on Friday, October 4th will be given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 2.93%. The ex-dividend date of this dividend is Wednesday, October 2nd.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.